ATE343590T1 - Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o - Google Patents
Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe oInfo
- Publication number
- ATE343590T1 ATE343590T1 AT98920571T AT98920571T ATE343590T1 AT E343590 T1 ATE343590 T1 AT E343590T1 AT 98920571 T AT98920571 T AT 98920571T AT 98920571 T AT98920571 T AT 98920571T AT E343590 T1 ATE343590 T1 AT E343590T1
- Authority
- AT
- Austria
- Prior art keywords
- radical
- seq
- peptide sequence
- formula
- val
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 238000012360 testing method Methods 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 6
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 is OH Chemical compound 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003573 thiols Chemical class 0.000 abstract 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9704356A FR2761993B1 (fr) | 1997-04-09 | 1997-04-09 | Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0 |
| FR9802212A FR2775287B1 (fr) | 1998-02-24 | 1998-02-24 | Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE343590T1 true ATE343590T1 (de) | 2006-11-15 |
Family
ID=26233456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98920571T ATE343590T1 (de) | 1997-04-09 | 1998-04-06 | Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7053175B1 (de) |
| EP (1) | EP0973802B1 (de) |
| JP (1) | JP3560987B2 (de) |
| KR (1) | KR100451312B1 (de) |
| CN (1) | CN1215082C (de) |
| AT (1) | ATE343590T1 (de) |
| AU (1) | AU740231B2 (de) |
| BR (1) | BRPI9809078B8 (de) |
| CA (1) | CA2286344C (de) |
| CZ (1) | CZ300927B6 (de) |
| DE (1) | DE69836265T2 (de) |
| ES (1) | ES2275305T3 (de) |
| IL (2) | IL132166A0 (de) |
| NO (1) | NO329149B1 (de) |
| NZ (1) | NZ500015A (de) |
| PL (1) | PL194863B1 (de) |
| PT (1) | PT973802E (de) |
| RU (1) | RU2184742C2 (de) |
| TR (1) | TR199902757T2 (de) |
| WO (1) | WO1998045323A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1215082C (zh) * | 1997-04-09 | 2005-08-17 | 比奥-拉德巴斯德公司 | 可用于检测o组hiv－1病毒感染的生物试验的合成肽 |
| CA2290217C (en) * | 1998-11-30 | 2010-01-12 | Ortho-Clinical Diagnostics, Inc. | Peptides for the detection of hiv-1 group o |
| FR2874017B1 (fr) | 2004-08-06 | 2006-11-24 | Bio Rad Pasteur Sa | Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih |
| US9658220B2 (en) | 2012-06-22 | 2017-05-23 | Bio-Rad Laboratories, Inc. | Human factor XIII as a normalization control for immunoassays |
| CN112481246B (zh) * | 2020-12-16 | 2022-03-29 | 熊猫乳品集团股份有限公司 | 一种生物活性多肽fspankkltpkky及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204259A (en) | 1988-05-06 | 1993-04-20 | Pharmacia Genetic Engineering, Inc. | Methods and systems for producing HIV antigens |
| DK0591914T4 (da) | 1992-10-06 | 2010-05-25 | Siemens Healthcare Diagnostics | Retrovirus fra HIV-gruppen og dets anvendelse |
| DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
| GB9410044D0 (en) | 1994-05-19 | 1994-07-06 | Int Murex Tech Corp | Assay |
| DE4430972A1 (de) | 1994-07-25 | 1996-02-01 | Boehringer Mannheim Gmbh | Bestimmung von spezifischem Immunglobulin unter Verwendung multipler Antigene |
| CA2202408C (fr) * | 1994-10-20 | 2012-03-06 | Pierre Charneau | Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o |
| DE19505262C2 (de) | 1995-02-16 | 1998-06-18 | Behring Diagnostics Gmbh | Retrovirus aus der HIV-Gruppe und dessen Verwendung |
| FR2731013B1 (fr) * | 1995-02-27 | 1997-05-16 | Inst Nat Sante Rech Med | Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications |
| WO1996027012A1 (en) | 1995-03-02 | 1996-09-06 | Akzo Nobel N.V. | Specific hiv-1 group o antigens |
| US5569553A (en) | 1995-03-08 | 1996-10-29 | Wilson Greatbatch Ltd. | Battery design for achieving end-of-life indication during electrical discharge |
| DE19622088A1 (de) | 1996-05-31 | 1997-12-04 | Boehringer Mannheim Gmbh | Anti-HIV-Antikörper als Kontrollproben |
| CN1215082C (zh) * | 1997-04-09 | 2005-08-17 | 比奥-拉德巴斯德公司 | 可用于检测o组hiv－1病毒感染的生物试验的合成肽 |
| CA2296442A1 (en) | 1997-07-18 | 1999-01-28 | Innogenetics N.V. | Hiv-1 group o antigens and uses thereof |
-
1998
- 1998-04-06 CN CNB988052024A patent/CN1215082C/zh not_active Expired - Lifetime
- 1998-04-06 TR TR1999/02757T patent/TR199902757T2/xx unknown
- 1998-04-06 KR KR10-1999-7009296A patent/KR100451312B1/ko not_active IP Right Cessation
- 1998-04-06 PT PT98920571T patent/PT973802E/pt unknown
- 1998-04-06 US US09/147,362 patent/US7053175B1/en not_active Expired - Lifetime
- 1998-04-06 BR BRPI9809078A patent/BRPI9809078B8/pt not_active IP Right Cessation
- 1998-04-06 DE DE69836265T patent/DE69836265T2/de not_active Expired - Lifetime
- 1998-04-06 PL PL336115A patent/PL194863B1/pl unknown
- 1998-04-06 AU AU73386/98A patent/AU740231B2/en not_active Expired
- 1998-04-06 ES ES98920571T patent/ES2275305T3/es not_active Expired - Lifetime
- 1998-04-06 EP EP98920571A patent/EP0973802B1/de not_active Expired - Lifetime
- 1998-04-06 IL IL13216698A patent/IL132166A0/xx active IP Right Grant
- 1998-04-06 JP JP54245598A patent/JP3560987B2/ja not_active Expired - Lifetime
- 1998-04-06 WO PCT/FR1998/000691 patent/WO1998045323A1/fr active IP Right Grant
- 1998-04-06 NZ NZ500015A patent/NZ500015A/en not_active IP Right Cessation
- 1998-04-06 RU RU99123443/04A patent/RU2184742C2/ru active
- 1998-04-06 CA CA2286344A patent/CA2286344C/fr not_active Expired - Lifetime
- 1998-04-06 CZ CZ0357599A patent/CZ300927B6/cs unknown
- 1998-04-06 AT AT98920571T patent/ATE343590T1/de not_active IP Right Cessation
-
1999
- 1999-09-30 IL IL132166A patent/IL132166A/en not_active IP Right Cessation
- 1999-10-08 NO NO19994929A patent/NO329149B1/no not_active IP Right Cessation
-
2006
- 2006-04-13 US US11/402,876 patent/US7838001B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Denkewalter et al. | Total synthesis of an enzyme. I. Objective and strategy | |
| Karplus et al. | Amino acid sequence of spinach ferredoxin: NADP oxidoreductase | |
| DE68913935D1 (de) | Verfahren zur Herstellung von Retro-Inverso-Peptiden und dessen Zwischenprodukte. | |
| Butler | Chemical studies on the cyanogen bromide peptides of rat skin collagen. Covalent structure of α1-CB5, the major hexose-containing cyanogen bromide peptide of α1 | |
| Atherton et al. | Peptide synthesis. Part 7. Solid-phase synthesis of conotoxin G1 | |
| CA2337967A1 (en) | Recombinant uricase protein | |
| Nolan et al. | Primary structure of the cytochrome c from the great grey kangaroo, Macropus canguru | |
| ATE343590T1 (de) | Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o | |
| GB1521919A (en) | Process for the manufacture of human insulin | |
| ATE290088T1 (de) | Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms | |
| Buck et al. | Comparative investigations on the amino-acid sequences of different isolectins from the sponge Axinella polypoides (Schmidt) | |
| IL142709A0 (en) | Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof | |
| Bruton | The infrastructure of valyl-transfer Ribonucleic Acid synthetase from yeast. | |
| ZA200109110B (en) | Long lasting fusion peptide inhibitors or viral infection. | |
| ATE135407T1 (de) | Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper | |
| Gish | Studies on the Amino Acid Sequence of Tobacco Mosaic Virus (TMV) Protein. IV. The Amino Acid Sequences of an Eicosapeptide and a Heptadecapeptide Isolated from a Tryptic Digest of TMV Protein1 | |
| AU623687B2 (en) | New pentapeptide and a process for the preparation thereof | |
| ATE85077T1 (de) | Enzym zur alpha-amidierung von c-termini und verfahren zu dessen herstellung. | |
| DE60125386D1 (de) | Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins | |
| Morley et al. | MPF analogue with high stability to proteolysis | |
| MX2023005771A (es) | Tetrapeptido y composiciones que comprenden tetrapeptidos. | |
| MX2023005770A (es) | Tetrapeptido y composiciones que comprenden tetrapeptidos. | |
| Aubert et al. | Circular dichroism studies on the proline-rich glycoprotein of human parotid saliva | |
| GB1532181A (en) | Pentapetides and a method of preparing them | |
| ES2063223T3 (es) | Anticuerpos contra secuencias de aminoacidos muy conservadas de sustancias inmunogenas, procedimiento para la preparacion de estos anticuerpos, asi como su utilizacion en inmunoensayos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |